prometheus biosciences acquisition：Merck to buy Prometheus Biosciences for about $11 billion
Merck to buy Prometheus Biosciences for about $11 billion
2023年4月17日—N)saidonSundayitwillbuyPrometheusBiosciencesInc(RXDX.O)forabout$10.8billion,pickingupapromisingexperimentaltreatmentfor ...。其他文章還包含有：「MerckCompletesAcquisitionofPrometheusBiosciences」、「MerckCompletesAcquisitionofPrometheusBiosciences」、「MerckFinalizes$10.8BPrometheusBuy」、「Merckinks$11BPrometheusbuyouttorivalRoivantinIBD...」、「MerckStrengthensImmunologyPipelin...
查看更多 離開網站
Merck Completes Acquisition of Prometheus Biosciences
https://www.merck.com
Under the terms of the acquisition agreement, Merck, through a subsidiary, has acquired all outstanding shares of Prometheus for $200.00 per ...
Merck Completes Acquisition of Prometheus Biosciences
https://merck2016rd.q4web.com
Under the terms of the acquisition agreement, Merck, through a subsidiary, has acquired all outstanding shares of Prometheus for $200.00 per ...
Merck Finalizes $10.8B Prometheus Buy
https://www.biospace.com
Merck finalized its acquisition of immune-focused Prometheus Biosciences for approximately $10.8 billion, scoring five clinical and pre ...
Merck inks $11B Prometheus buyout to rival Roivant in IBD ...
https://www.fiercebiotech.com
Merck & Co. is paying $10.8 billion to buy Prometheus Biosciences for its late-phase bowel disease drug candidate.
Merck Strengthens Immunology Pipeline with Acquisition of ...
https://www.merck.com
Under the terms of the acquisition agreement, Merck, through a subsidiary, will acquire all of the outstanding shares of Prometheus. The ...
MSD Completes Acquisition of Prometheus Biosciences
https://www.msd.com
Under the terms of the acquisition agreement, MSD, through a subsidiary, has acquired all outstanding shares of Prometheus for $200.00 per share ...